Immersive Virtual Reality Seems to Ease Cancer Patients' Pain and Distress

Immersive virtual reality - digital technology that allows a person to experience being physically present in a non-physical world - seems to ease the pain and distress felt by patients with cancer, suggests a pooled data analysis of the available evidence published in BMJ Supportive & Palliative Care.

The technology may also have potential for people with other distressing long term conditions, such as multiple sclerosis (MS), kidney disease, and dementia, the findings indicate.

As the physical and practical costs of virtual reality technologies have fallen, interest in their use for improving patients’ quality of life has grown, note the researchers. But it’s not clear how effective they might be in helping people cope with the medical treatment and psychological impact of a long term condition.

To explore this further, the researchers trawled research databases for studies that looked at the use and effectiveness of immersive virtual reality for aiding psychological adjustment to a long term condition in adults.

They found 31 relevant studies, published between 1993 and 2023, in which the technology had been used in patients with cancer (16), dementia (5), cardiovascular disease (4), MS (2), kidney disease (2), inflammatory bowel disease (1), and chronic obstructive pulmonary disease (1).

The studies ranged in size from 30 to 50 participants, with an average age of 51. Three out of four participants were women. On average, a virtual reality session lasted 20 minutes, ranging in delivery from one application to daily for a specified period.

The studies looked at environment-based and game-based immersive virtual reality interventions, designed either to relax the user ahead of medical treatment with a combination of a nature walk and mindfulness meditation, for example, or to engage them by equipping them with specific skills or behaviours to help them cope better with their condition.

Pooling the study results showed that patients were happy to use immersive virtual reality and that it helped those with cancer, dementia, cardiovascular disease, MS and kidney disease cope better with required medical treatments and the emotional impact of their condition.

The types of virtual reality and procedures used varied widely across the included studies, and no one particular type emerged as noticeably more effective than any of the others.

But 13 of the 31 included studies were feasibility or pilot studies, and a further 4 were considered to have a high risk of bias. Sample sizes were often small and not many studies included a comparison group, meaning that a degree of caution is required in interpreting these findings, emphasise the researchers.

Exactly how immersive virtual realities might exert their physical and psychological effects on patients still isn’t clear, they say.

The technology might be distracting and absorbing, or alter the user’s state of mind, so reducing the subjective experience of pain and/or boosting their ability to cope with the physical and psychological impacts of their condition, suggest the researchers.

"These findings are promising in a population at risk of polypharmacy, and suggest immersive VR [virtual reality] can offer a non-pharmacological intervention that is considered acceptable by clinicians, caregivers, and patients," they write.

"As VR systems become progressively more accessible, immersive VR interventions may begin to offer cost benefits compared with conventional pharmacological and non-pharmacological treatments," they add.

Further research is needed to better understand how the technology works, if any particular type is more effective and under what circumstances, and what, if any, long term effects there might be, they note.

But they conclude: "Our findings suggest that VR interventions are acceptable treatments that have the potential to improve physical and psychological consequences of physical illness. There is good quality research to suggest that these VR interventions are effective in reducing pain and distress, particularly among people with cancer."

McGhee WRG, Doherty CJ, Graham-Wisener L, et al.
Immersive virtual reality and psychological well-being in adult chronic physical illness: systematic review.
BMJ Supportive & Palliative Care, 2023. doi: 10.1136/spcare-2023-004502

Most Popular Now

MEDICA 2024 + COMPAMED 2024: Adapted Hal…

11 - 14 November 2024, Düsseldorf, Germany. The final preparations for MEDICA 2024 and COMPAMED 2024 in Düsseldorf have begun. A total of more than 5,500 exhibitors from approximately 70 countries...

AI does Not Necessarily Lead to more Eff…

The use of artificial intelligence (AI) in hospitals and patient care is steadily increasing. Especially in specialist areas with a high proportion of imaging, such as radiology, AI has long...

Commission Joins Forces with Venture Cap…

The Commission has launched a Trusted Investors Network bringing together a group of investors ready to co-invest in innovative deep-tech companies in Europe together with the EU. The Union's investment...

Why the NHS is Seeking to Make Media Ser…

Opinion Article by Dean Moody, Healthcare Services Director, Airwave Healthcare. Tim Kelsey and Martha Lane Fox called for WiFi to be made available free of charge throughout the NHS back in...

An AI-Powered Pipeline for Personalized …

Ludwig Cancer Research scientists have developed a full, start-to-finish computational pipeline that integrates multiple molecular and genetic analyses of tumors and the specific molecular targets of T cells and harnesses...

Philips and Medtronic Advocacy Partnersh…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Medtronic Neurovascular, a leading innovator in neurovascular therapies, today announced a strategic advocacy partnership. Delivering timely stroke...

Wearable Cameras Allow AI to Detect Medi…

A team of researchers says it has developed the first wearable camera system that, with the help of artificial intelligence (AI), detects potential errors in medication delivery. In a test whose...

AI could Transform How Hospitals Produce…

A pilot study led by researchers at University of California San Diego School of Medicine found that advanced artificial intelligence (AI) could potentially lead to easier, faster and more efficient...

New AI Tool Predicts Protein-Protein Int…

Scientists from Cleveland Clinic and Cornell University have designed a publicly-available software and web database to break down barriers to identifying key protein-protein interactions to treat with medication. The computational tool...

Great Start for Ideas and Innovations: D…

8 - 10 April 2025, Berlin, Germany. From 15 October to 15 November 2024, the DMEA invites experts from business, science, politics and practice to actively participate in shaping the congress...

Start-Ups will Once Again Have a Starrin…

11 - 14 November 2024, Düsseldorf, Germany. The finalists in the 16th Healthcare Innovation World Cup and the 13th MEDICA START-UP COMPETITION have advanced from around 550 candidates based in 62...

AI for Real-Rime, Patient-Focused Insigh…

A picture may be worth a thousand words, but still... they both have a lot of work to do to catch up to BiomedGPT. Covered recently in the prestigious journal Nature...